furosemide has been researched along with hydroxychloroquine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mustard, JF; Packham, MA | 1 |
Bickers, DR; Harber, LC | 1 |
Lefebvre, PJ; Luyckx, AS | 1 |
Moss, RB | 1 |
Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W | 1 |
Gota, C; Khasnis, A; Shahane, A | 1 |
Gimovsky, M; Juusela, A; Nazir, M | 1 |
3 review(s) available for furosemide and hydroxychloroquine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
6 other study(ies) available for furosemide and hydroxychloroquine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Porphyria and pseudoporphyria.
Topics: Alcoholism; Bloodletting; Female; Furosemide; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Male; Nalidixic Acid; Porphyrias; Skin Diseases; Terminology as Topic; Tetracycline | 1984 |
Endogenous prostaglandins modulate glucagon secretion by isolated guinea-pig islets.
Topics: Animals; Arachidonic Acids; Arginine; Furosemide; Glucagon; Guinea Pigs; Hydroxychloroquine; In Vitro Techniques; Indomethacin; Islets of Langerhans; Male; Prostaglandins E | 1980 |
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone | 2008 |
Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Diuretics; Drug Therapy, Combination; Female; Furosemide; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Rituximab; Treatment Outcome | 2012 |
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Blood Gas Analysis; Cardiomyopathies; Cesarean Section; COVID-19; COVID-19 Nucleic Acid Testing; Diabetes, Gestational; Diuretics; Echocardiography; Enzyme Inhibitors; Female; Fever; Furosemide; Heart Arrest; Heart Failure; Humans; Hydroxychloroquine; Hypoxia; Intubation, Intratracheal; Magnesium Sulfate; Metoprolol; Middle Aged; Obesity, Maternal; Oxygen Inhalation Therapy; Point-of-Care Systems; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Infectious; Respiration, Artificial; Return of Spontaneous Circulation; SARS-CoV-2; Severity of Illness Index; Stroke Volume; Tachycardia; Tachycardia, Supraventricular | 2020 |